Literature DB >> 33432324

Deciphering the genetic code of DNA methylation.

Mengchi Wang1, Vu Ngo1, Wei Wang2.   

Abstract

DNA methylation plays crucial roles in many biological processes and abnormal DNA methylation patterns are often observed in diseases. Recent studies have shed light on cis-acting DNA elements that regulate locus-specific DNA methylation, which involves transcription factors, histone modification and DNA secondary structures. In addition, several recent studies have surveyed DNA motifs that regulate DNA methylation and suggest potential applications in diagnosis and prognosis. Here, we discuss the current biological foundation for the cis-acting genetic code that regulates DNA methylation. We review the computational models that predict DNA methylation with genetic features and discuss the biological insights revealed from these models. We also provide an in-depth discussion on how to leverage such knowledge in clinical applications, particularly in the context of liquid biopsy for early cancer diagnosis and treatment.
© The Author(s) 2021. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  DNA methylation; DNA motif; cancer; cfDNA; liquid biopsy

Mesh:

Year:  2021        PMID: 33432324      PMCID: PMC8425266          DOI: 10.1093/bib/bbaa424

Source DB:  PubMed          Journal:  Brief Bioinform        ISSN: 1467-5463            Impact factor:   11.622


  114 in total

Review 1.  DNA methylation and human disease.

Authors:  Keith D Robertson
Journal:  Nat Rev Genet       Date:  2005-08       Impact factor: 53.242

Review 2.  Linking DNA methylation and histone modification: patterns and paradigms.

Authors:  Howard Cedar; Yehudit Bergman
Journal:  Nat Rev Genet       Date:  2009-05       Impact factor: 53.242

Review 3.  Structure and function of mammalian DNA methyltransferases.

Authors:  Renata Zofia Jurkowska; Tomasz Piotr Jurkowski; Albert Jeltsch
Journal:  Chembiochem       Date:  2010-11-29       Impact factor: 3.164

4.  CTCF mediates long-range chromatin looping and local histone modification in the beta-globin locus.

Authors:  Erik Splinter; Helen Heath; Jurgen Kooren; Robert-Jan Palstra; Petra Klous; Frank Grosveld; Niels Galjart; Wouter de Laat
Journal:  Genes Dev       Date:  2006-09-01       Impact factor: 11.361

5.  DNA methylation in serum of breast cancer patients: an independent prognostic marker.

Authors:  Hannes M Müller; Andreas Widschwendter; Heidi Fiegl; Lennart Ivarsson; Georg Goebel; Elisabeth Perkmann; Christian Marth; Martin Widschwendter
Journal:  Cancer Res       Date:  2003-11-15       Impact factor: 12.701

Review 6.  PTEN: a new guardian of the genome.

Authors:  Y Yin; W H Shen
Journal:  Oncogene       Date:  2008-09-18       Impact factor: 9.867

7.  CpG islands influence chromatin structure via the CpG-binding protein Cfp1.

Authors:  John P Thomson; Peter J Skene; Jim Selfridge; Thomas Clouaire; Jacky Guy; Shaun Webb; Alastair R W Kerr; Aimée Deaton; Rob Andrews; Keith D James; Daniel J Turner; Robert Illingworth; Adrian Bird
Journal:  Nature       Date:  2010-04-15       Impact factor: 49.962

8.  Methylation patterns in serum DNA for early identification of disseminated breast cancer.

Authors:  Martin Widschwendter; Iona Evans; Allison Jones; Shohreh Ghazali; Daniel Reisel; Andy Ryan; Aleksandra Gentry-Maharaj; Michal Zikan; David Cibula; Johannes Eichner; Marianna Alunni-Fabbroni; Julian Koch; Wolfgang J Janni; Tobias Paprotka; Timo Wittenberger; Usha Menon; Benjamin Wahl; Brigitte Rack; Harri Lempiäinen
Journal:  Genome Med       Date:  2017-12-22       Impact factor: 11.117

9.  CpGIMethPred: computational model for predicting methylation status of CpG islands in human genome.

Authors:  Hao Zheng; Hongwei Wu; Jinping Li; Shi-Wen Jiang
Journal:  BMC Med Genomics       Date:  2013-01-23       Impact factor: 3.063

Review 10.  Epigenetic mechanisms as a new approach in cancer treatment: An updated review.

Authors:  Masoumeh Fardi; Saeed Solali; Majid Farshdousti Hagh
Journal:  Genes Dis       Date:  2018-06-18
View more
  7 in total

1.  Chromobox 4 (CBX4) promotes tumor progression and stemness via activating CDC20 in gastric cancer.

Authors:  Wen Li; Honghui Chen; Zhenggen Wang; Jingjing Liu; Xinan Lei; Wen Chen
Journal:  J Gastrointest Oncol       Date:  2022-06

2.  Large-Scale Transcriptome Data Analysis Identifies KIF2C as a Potential Therapeutic Target Associated With Immune Infiltration in Prostate Cancer.

Authors:  Pingxin Zhang; Hang Gao; Chunwei Ye; Ruping Yan; Lu Yu; Chengxing Xia; Delin Yang
Journal:  Front Immunol       Date:  2022-06-03       Impact factor: 8.786

3.  Analysis of Pan-Cancer Revealed the Immunological and Prognostic Potential of CBX3 in Human Tumors.

Authors:  Haitao Xu; Caihong Jiang; Dangui Chen; Youzhi Wu; Jia Lu; Long Zhong; Fusheng Yao
Journal:  Front Med (Lausanne)       Date:  2022-04-28

4.  Prognostic and Immunological Role of PPP1R14A as a Pan-Cancer Analysis Candidate.

Authors:  Zhaotao Wang; Rihong Huang; Haojian Wang; Yuecheng Peng; Yongyang Fan; Zejia Feng; Zhaorong Zeng; Yunxiang Ji; Yezhong Wang; Jiajie Lu
Journal:  Front Genet       Date:  2022-05-17       Impact factor: 4.772

5.  Pancancer Analysis of the Oncogenic and Prognostic Role of NOL7: A Potential Target for Carcinogenesis and Survival.

Authors:  Qiaojun Liu; Renjian Xie; Yumei Li
Journal:  Int J Mol Sci       Date:  2022-08-25       Impact factor: 6.208

6.  High FLT3 expression indicates favorable prognosis and correlates with clinicopathological parameters and immune infiltration in breast cancer.

Authors:  Rui Chen; Xinyang Wang; Jingyue Fu; Mengdi Liang; Tiansong Xia
Journal:  Front Genet       Date:  2022-09-08       Impact factor: 4.772

7.  Pan-Cancer Analysis of the Prognostic and Immunological Role of HSF1: A Potential Target for Survival and Immunotherapy.

Authors:  Fei Chen; Yumei Fan; Pengxiu Cao; Bing Liu; Jiajie Hou; Bo Zhang; Ke Tan
Journal:  Oxid Med Cell Longev       Date:  2021-06-18       Impact factor: 6.543

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.